Summary.
There exists considerable evidence implicating abnormalities of the alpha (α)-adrenergic system in the development of Alzheimer disease (AD). We propose to investigate potential correlations between the presence or otherwise of α-adrenoceptor polymorphisms and the presence of AD. We studied the polymorphisms of the α1a- and the α2a-adrenoceptor genes in 142 AD patients and 98 normal controls. The result demonstrated that none of the α2a-adrenoceptor genotypes was associated with increased susceptibility to AD. However, there was a trend that the frequency of the C allele of the α1a-adrenoceptor was elevated and an excess of the CC genotype (90.1%) was found in the subjects with AD in comparison with the controls (78.6%). This association was unrelated to the apolipoprotein E genotypes. The hypothesis that the α1a-adrenoceptor gene may be implicated in the pathogenesis of AD may deserve further study.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received January 24, 2000; accepted November 21, 2000
Rights and permissions
About this article
Cite this article
Hong, CJ., Wang, YC., Liu, TY. et al. A study of alpha-adrenoceptor gene polymorphisms and Alzheimer disease. J Neural Transm 108, 445–450 (2001). https://doi.org/10.1007/s007020170065
Issue Date:
DOI: https://doi.org/10.1007/s007020170065